Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Pharma and Biotech Daily: From Antitrust Probes to Nanoparticle Innovations

Pharma and Biotech Daily: From Antitrust Probes to Nanoparticle Innovations

FromPharma and BioTech Daily


Pharma and Biotech Daily: From Antitrust Probes to Nanoparticle Innovations

FromPharma and BioTech Daily

ratings:
Length:
3 minutes
Released:
Feb 29, 2024
Format:
Podcast episode

Description

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.UnitedHealth is facing an antitrust probe by the DOJ regarding potential anticompetitive effects. Despite challenges like high labor costs, UHS, a hospital operator, saw revenue growth in 2023. Veradigm is set to delist after missing a Nasdaq deadline. Nurse leaders report burnout and turnover in their roles. A ransomware attack at an urgent care provider may have exposed personal information of over 516,000 people. Healthcare Dive provides insights for healthcare leaders, including articles on AI implementation, social determinants of health, and healthcare data breaches, covering a wide range of topics such as hospitals, payers, health IT, government policies, finances, medical groups, and telehealth. Healthcare Dive is operated by Industry Dive, providing journalism and insights for decision-makers in competitive industries.Viatris pays $350 million to acquire two drugs from Idorsia for heart attacks and lupus in phase 3 testing. Ginkgo acquires gene editing tools through the buyout of Proof Diagnostics, founded by Feng Zhang. Incannex reports that psilocybin therapy reduced anxiety in a small study. Women's health company Obseva plans to wind down operations and lay off staff. Viking's obesity drug showed promising results in a phase 2 trial, potentially rivaling drugs from Eli Lilly and Novo Nordisk. The rise of obesity drug treatments is reshaping the pharma industry with significant advancements and changes, as companies make strategic moves to enhance their portfolios and address unmet medical needs.Gatorade has unveiled Gatorade Water, their first unflavored water product, with a digital-heavy marketing campaign focused on wellness. Estee Lauder's marketing mix modeling use was discussed at the eTail Palm Springs conference, showcasing their balance between brand and performance marketing. Dick's Sporting Goods has enlisted Kathryn Hahn and Will Arnett for an ad campaign highlighting e-commerce convenience. Food and beverage brands are putting a modern spin on retro packaging to appeal to consumers' emotions. Mod Op has acquired RTO+P for more creative firepower in a competitive market. Marketing Dive explores mobile messaging's influence on consumer behavior in 2024, as well as upcoming events and industry news.The recent awarding of Johnson & Johnson's Dr. Paul Janssen Award for Biomedical Research to MIT professor and Moderna co-founder Robert Langer is discussed in the text, recognizing his impactful innovations in drug delivery. Langer's work in nanoparticle drug delivery has led to advancements in biopharma, particularly in the technology behind mRNA vaccines. The text also highlights Langer's role as a scientific advisor to a new CRO aiming to improve clinical trials through technology. Additionally, it addresses the staffing challenges faced by CROs since the pandemic and explores strategies for retaining talent in the research industry, emphasizing the importance of adapting to new technologies and approaches to enhance efficiency in clinical trials and improve patient care.
Released:
Feb 29, 2024
Format:
Podcast episode

Titles in the series (50)

 This podcast aims to bring you a daily summary of most relevant news in Pharma and BioTech world, fully automated and Generated by ChatGPT.  If you're interested in similar podcast checkout www.owith.ai